Compare CASH & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CASH | ALMR |
|---|---|---|
| Founded | 1954 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1996 | 2026 |
| Metric | CASH | ALMR |
|---|---|---|
| Price | $83.68 | $34.24 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $107.50 | N/A |
| AVG Volume (30 Days) | 167.3K | ★ 299.0K |
| Earning Date | 04-22-2026 | N/A |
| Dividend Yield | ★ 0.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 6.29 | N/A |
| Revenue | ★ $839,894,000.00 | N/A |
| Revenue This Year | $7.56 | N/A |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | $13.35 | ★ N/A |
| Revenue Growth | ★ 11.29 | N/A |
| 52 Week Low | $65.93 | $21.58 |
| 52 Week High | $101.26 | $38.54 |
| Indicator | CASH | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 36.97 | 65.56 |
| Support Level | $80.30 | $32.00 |
| Resistance Level | $85.41 | $38.54 |
| Average True Range (ATR) | 1.59 | 2.81 |
| MACD | -0.54 | 0.44 |
| Stochastic Oscillator | 12.41 | 68.10 |
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.